At Omics! Omics!, Keith Robison reports that Pfizer has filed a patent based on a Gene Logic drug repositioning effort. Drug repositioning is finding new uses for advanced drugs that ultimately were never approved, and Gene Logic is just one of a handful of companies hoping to make money off these compounds. The question remains, will it be the big pharmas or small biotechs that can actually get these through clinical trials?

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.